TR199800543A2 - Benziloksi ikame edilen, aniliye edilmis N-heterosiklik bilesikler. - Google Patents

Benziloksi ikame edilen, aniliye edilmis N-heterosiklik bilesikler.

Info

Publication number
TR199800543A2
TR199800543A2 TR1998/00543A TR9800543A TR199800543A2 TR 199800543 A2 TR199800543 A2 TR 199800543A2 TR 1998/00543 A TR1998/00543 A TR 1998/00543A TR 9800543 A TR9800543 A TR 9800543A TR 199800543 A2 TR199800543 A2 TR 199800543A2
Authority
TR
Turkey
Prior art keywords
anilylated
heterocyclic compounds
benzyloxy substituted
benzyloxy
substituted
Prior art date
Application number
TR1998/00543A
Other languages
English (en)
Inventor
Holger Heitsch Dr.
Adalbert Wagner Dr.
Klaus Wirth Dr.
BERNWARD SCH�LKENS Prof.Dr.
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of TR199800543A2 publication Critical patent/TR199800543A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bulusun konusu, asagidaki formül (I)'e sahip olan Formül (I) ve semboller B, D, R1 ve R2'nin patent istemlerinde belirtilen anlamlara geldigi bilesikler, bunlarin üretimine yönelik bir yöntem ve bunlarin karaciger sirozu ve Alzheimer hastaliginin tedavisine yönelik ilaçlar olarak kullanimi ile ilgilidir.
TR1998/00543A 1997-03-27 1998-03-25 Benziloksi ikame edilen, aniliye edilmis N-heterosiklik bilesikler. TR199800543A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712960A DE19712960A1 (de) 1997-03-27 1997-03-27 Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten

Publications (1)

Publication Number Publication Date
TR199800543A2 true TR199800543A2 (tr) 1998-10-21

Family

ID=7824838

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00543A TR199800543A2 (tr) 1997-03-27 1998-03-25 Benziloksi ikame edilen, aniliye edilmis N-heterosiklik bilesikler.

Country Status (16)

Country Link
US (1) US6211196B1 (tr)
EP (1) EP0867432B1 (tr)
JP (1) JPH10279563A (tr)
KR (1) KR19980080757A (tr)
CN (1) CN1194978A (tr)
AT (1) ATE268759T1 (tr)
AU (1) AU5965298A (tr)
BR (1) BR9801132A (tr)
CA (1) CA2232499A1 (tr)
CZ (1) CZ91498A3 (tr)
DE (2) DE19712960A1 (tr)
ES (1) ES2223090T3 (tr)
HU (1) HUP9800649A3 (tr)
NO (1) NO981383L (tr)
PL (1) PL325597A1 (tr)
TR (1) TR199800543A2 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10134721A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Tetrahydrochinoxaline
US6492517B1 (en) 2001-07-19 2002-12-10 Air Products And Chemicals, Inc. Method for preparing halomethyl heterocyclic compounds
US6958349B2 (en) * 2002-04-10 2005-10-25 Ortho-Mcneil Pharmaceuticals, Inc. Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
WO2003093245A1 (en) * 2002-05-03 2003-11-13 Elan Pharmaceuticals, Inc. Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
MX2007010572A (es) 2005-03-01 2007-10-04 Wyeth Corp Compuestos de cinolina y su uso como moduladores de receptor x de higado.
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
JP6479854B2 (ja) 2014-05-07 2019-03-06 エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＥｖｏｔｅｃ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ 医薬組成物のためのスルホキシイミン置換キナゾリン
WO2019101906A1 (en) 2017-11-24 2019-05-31 Pharvaris B.V. Novel bradykinin b2 receptor antagonists
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
PT4203919T (pt) 2021-08-05 2024-04-23 Pharvaris Gmbh Composição à base de lípidos para administração oral de antagonistas do recetor b2 da bradicinina
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202336A (en) * 1986-09-24 1993-04-13 Bayer Aktiengesellschaft Antiflammatory quinolin methoxy phenylsulphonamides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
CN1168667A (zh) * 1994-10-27 1997-12-24 藤沢药品工业株式会社 用作缓激肽拮抗剂的吡啶并嘧啶酮，喹啉和稠合的n-杂环化合物
FR2735128B1 (fr) * 1995-06-07 1997-07-25 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
FR2737892B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique
GB9519077D0 (en) * 1995-09-18 1995-11-15 Fujisawa Pharmaceutical Co New heterocyclic compounds
DE19610784A1 (de) * 1996-03-19 1997-09-25 Hoechst Ag Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0808627A2 (de) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DK0835659T3 (da) * 1996-10-14 2005-04-18 Aventis Pharma Gmbh Anvendelse af ikke-peptidiske antagonister for bradykinin til fremstilling af lægemidler til behandling og forebyggelse af Alzheimer's sygdom

Also Published As

Publication number Publication date
US6211196B1 (en) 2001-04-03
ATE268759T1 (de) 2004-06-15
DE59811526D1 (de) 2004-07-15
ES2223090T3 (es) 2005-02-16
PL325597A1 (en) 1998-09-28
EP0867432A3 (de) 1998-10-14
CN1194978A (zh) 1998-10-07
EP0867432A2 (de) 1998-09-30
MX9802372A (es) 1998-09-30
HUP9800649A2 (hu) 1998-12-28
JPH10279563A (ja) 1998-10-20
AU5965298A (en) 1998-10-01
CZ91498A3 (cs) 1998-10-14
NO981383D0 (no) 1998-03-26
EP0867432B1 (de) 2004-06-09
HU9800649D0 (en) 1998-05-28
KR19980080757A (ko) 1998-11-25
NO981383L (no) 1998-09-28
BR9801132A (pt) 2000-03-21
CA2232499A1 (en) 1998-09-27
DE19712960A1 (de) 1998-10-01
HUP9800649A3 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
TR199800543A2 (tr) Benziloksi ikame edilen, aniliye edilmis N-heterosiklik bilesikler.
BR9806752A (pt) Ftalazinonas.
DZ3482A1 (fr) Secretagogues de l'hormone de croissance
DK1200418T3 (da) Nematodicide trifluorbutener
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
PT1140945E (pt) Derivados 1 2 4 tiadiazina fundidos a sua preparacao e a sua utilizacao
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
DK1485359T3 (da) Natriumkanalblokkere
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
TR199902094T2 (tr) 3-Heteroareil-4(3H)-kinazolinonlarin atropizomerleri.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
UA66866C2 (uk) Синтез морфолінових похідних
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
SE9504618D0 (sv) New Compounds
DE59910585D1 (en) 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
ID27440A (id) Proses untuk menyiapkan penengah-penengah
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
BR0010488A (pt) Tienocicloalqu(en)ilamino-1,3,5-triazinas substituìdas
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof